Adult T-cell leukemia medical therapy

Adult T-cell leukemia Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Adult T-cell leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-Ray Findings
Echocardiography and Ultrasound
CT scan
MRI Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Adult T-cell leukemia medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Adult T-cell leukemia medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Adult T-cell leukemia medical therapy
CDC on Adult T-cell leukemia medical therapy
Adult T-cell leukemia medical therapy in the news
Blogs on Adult T-cell leukemia medical therapy
Directions to Hospitals Treating Adult T-cell leukemia
Risk calculators and risk factors for Adult T-cell leukemia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

The common regimens used to treat adult T-cell leukemia include

• CHOP regimen - cyclophosphamide, doxorubicin,vincristine and prednisone
• EPOCH regimen - etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone